tm logo
MISUVYA
REGISTERED

on 11 Jul 2022

Last Applicant/ Owned by

ELI LILLY AND COMPANY

Lilly Corporate CenterIndianapolis, IN 46285

US

Serial Number

1932440 filed on 26th Nov 2018

Registration Number

TMA1133640 registered on 11th Jul 2022

Registration expiry Date

11th Jul 2032

Correspondent Address

World Exchange Plaza100 Queen Street, Suite 1300Ottawa

ONTARIO

CA

K1P1J9

MISUVYA

Trademark usage description

pharmaceutical preparations namely pharmaceutical preparations for the treatment of alopecia, alzheimer's disease, atopic dermatitis, autoimmune disea Read More

Classification Information


Class [005]
Pharmaceutical preparations namely pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders namely osteoporosis, osteoarthritis, fracture healing, bone frailty due to extended ventilator use, hip replacement surgery and knee replacement surgery, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, arthritis, bursitis, tendonitis, osteonecrosis and Paget's disease, cancer, cardiovascular diseases, central nervous system diseases and disorders namely, anxiety disorders, depression, bipolar depression, bipolar disorder, treatment resistant depression, schizophrenia and cognitive impairment associated with schizophrenia, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders namely psoriasis, skin cancer and eczema, diabetes, dyslipidemia, endocrine diseases and disorders, namely Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus, gastrointestinal diseases and disorders, headaches, heart failure, hypoglycemia, inflammation and inflammatory diseases and disorders namely inflammatory bowel diseases, inflammatory connective tissue diseases and rheumatoid arthritis, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, namely mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy and cerebral palsy, metabolic diseases and disorders namely metabolic syndrome, migraines, multiple sclerosis, muscle diseases and disorders namely myopathies, chronic fatigue syndrome, fibromyalgia and muscular dystrophy, neurodegenerative diseases and disorders namely Huntington's disease, Alzheimer's disease, and dementia, neurological disorders namely Alzheimer's disease, mild cognitive impairment, Parkinson's disease and multiple sclerosis, obesity, pain relief, Parkinson's disease, psoriasis, psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, ulcerative colitis; Diagnostic reagents for medical diagnostic use; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases and of oncology and of pain.


Classification kind code

11

Mark Details


Serial Number

1932440

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 191
on 06th Jul 2022
Registration Fee Notice Sent
Submitted for opposition 42
on 13th Apr 2022
Advertised
Submitted for opposition 26
on 02th Feb 2022
Approved
Submitted for opposition 27
on 02th Feb 2022
Approval Notice Sent
Submitted for opposition 48
on 01st Feb 2022
Agent Changed
Submitted for opposition 22
on 30th Jul 2021
Search Recorded
Submitted for opposition 20
on 30th Jul 2021
Examiner's First Report
Submitted for opposition 31
on 28th Nov 2018
Formalized
Submitted for opposition 1
on 27th Nov 2018
Created
Submitted for opposition 30
on 26th Nov 2018
Filed